Skip to main content
Market intelligence
ATYRHealthcare

Atyr Pharma Inc insider activity

In the last 90 days, 1 corporate insider purchased $49,630 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$49,630
Corporate buyers
1
Latest transaction
May 27, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 27, 2026Paul SchimmelDirectorOpen Market Purchase100,000$0.50$49,630